We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

MGI Tech Co., Ltd.

MGI Tech Co., Ltd. produces sequencing instruments, reagents, equipment and related products to support life science ... read more Featured Products: More products

Download Mobile App





MGI Tech Launches New MGISP-Smart 8 Automated Sample Preparation System at MEDLAB Middle East

By LabMedica International staff writers
Posted on 24 Jan 2022

MGI Tech Co. More...

Ltd. (Shenzhen, China) unveiled its new MGISP-Smart 8 automated sample preparation system at MEDLAB Middle East 2022 held at the Dubai World Trade Center.

The event marked the debut of the MGISP-Smart 8 in international markets outside of China, where it was launched in October 2021. MGISP-Smart 8 will now be available in markets outside of China in April 2022. Additionally, MGI Tech also showcased its DNBSEQ-G400 and DNBSEQ-G50 gene sequencing platforms, MGISTP-3000 automated sample transfer processing system, mobile platform for automated and integrated nucleic acid testing.

MGISP-Smart 8 is an independent 8-channel pipetting robot that achieves flexible and customizable lab automation with several innovations in the pipette and gripper functions, such as independent multi-channel dynamic positioning and dual-level liquid detection. Equipped with high-end core technologies, such as an independent 8-channel pipette, intelligent integrated gripper and triple slide track design, MGISP-Smart 8 meets a variety of different application needs, from sequencing library preparation to nucleic acid detection and sample preparation.

MGISP-Smart 8 automates the pipetting and gripper function, which are two core functions for laboratories. With its independent eight-channel pipette for cherry-picking, the system flexibly and efficiently controls pipetting for a variety of lab scenarios and tasks. The system's pipetting volume ranges from 1μL to 1000μL, and eight independent pipettes support dual-level liquid detection for capacitance and pressure. MGISP-Smart 8 is also capable of undertaking pipette functions for different volumes, different channels and unequal intervals - making it adaptable to microplates, reservoirs and tubes. Meanwhile, the high precision integrated rotatable gripper directly connects to the peripheral integration instrument and detects gripping status in real-time to ensure experiment stability.

Beyond the pipette and gripper functions, MGISP-Smart 8 is extremely user-friendly and flexible with exceptional attention to details. The main workstation's triple stacked sliding deck design is adaptable to different modules, allowing users to flexibly combine modules like building blocks and conveniently replace modules at any time for applications' protocols. With 36 independent sliding tracks on the deck, MGISP-Smart 8 supports up to 30 SBS-standard layouts and works with seven types of consumable carriers. All tracks and deck positions are equipped with a position-sensing function, as well as induction functions to avoid misplacement errors in carrier and consumable advancement. MGISP-Smart 8 also works with different types of functional modules and is compatible with third-party kits with flexible software. As a flexible automated pipetting system, MGISP-Smart 8 covers different application scenarios in genomics, cell biology, proteomics, drug development, microbial screening and more. By fully automating operations, laboratories can improve efficiency; reduce errors in complex, repetitive liquid handling protocols; and free out researchers from tedious sample preparation work so they can devote more time onto more valuable tasks.

"Since our inception, MGI has been committed to developing our automated sample preparation systems business. The MGISP-960 and MGISP-100 have helped simplify tedious sample preparation tasks and been well-received by the international medical and scientific community, while the MGISTP-7000 automated sample transfer processing system and MGISP-NE384 automated nucleic acid extractor have supported pandemic prevention efforts for a number of countries worldwide. With the new MGISP-Smart 8, we have once again made a major breakthrough in lab automation. MGISP-Smart 8 builds on our existing systems with greater flexibility, intelligence and customization – enabling us to provide comprehensive lab automatic workflow for more fields and applications," said Dr. Roy Tan, General Manager of MGI Asia Pacific.

Related Links:
MGI Tech Co. Ltd. 


Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Epstein-Barr Virus Test
Mononucleosis Rapid Test
New
Luteinizing Hormone Assay
DRG LH-Serum ELISA Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.